A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinoma

Gerardo Rosati, G. Ambrosini, Sandro Barni, +23

Annals of Oncology

Surgical OncologyGastrointestinal OncologyCancer ScreeningColorectal SurgeryMedicine +8

Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin, glutathione, and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer.

Stefano Cascinu, Roberto Labianca, Paolo Alessandroni, +11

Journal of Clinical Oncology

A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)

Stefano Cascinu, Rosa Rita Silva, Sandro Barni, +11

British Journal of Cancer

Folinic acid + 5-Fluorouracil (5-FU) versus equidose 5-FU in advanced colorectal cancer. Phase III study of ‘GISCAD’ (Italian Group for the Study of Digestive Tract Cancer)

Roberto Labianca, G. Pancera, Enrico Aitini, +17

Annals of Oncology

Gastrointestinal OncologyGastrointestinal PharmacologyMedicinePharmacologyGastroenterology +8

A phase I–II study of gemcitabine and docetaxel in advanced pancreatic cancer: A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)

Stefano Cascinu, Giulio Gasparini, Vincenzo Catalano, +6

Annals of Oncology

Pancreatic CancerGastrointestinal OncologyMedicineGastroenterologyPathology +7

Intensive weekly chemotherapy for locally advanced gastric cancer using 5-fluorouracil, cisplatin, epidoxorubicin, 6S-leucovorin, glutathione and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)

Stefano Cascinu, Roberto Labianca, Francesco Graziano, +6

British Journal of Cancer

Surgical OncologyOncologyGastrointestinal OncologyGastrointestinal PharmacologyAdvanced Gastric Cancer +7

Weekly gemcitabine and cisplatin chemotherapy: a well-tolerated but ineffective chemotherapeutic regimen in advanced pancreatic cancer patients. A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)

Stefano Cascinu, Roberto Labianca, Vincenzo Catalano, +10

Annals of Oncology

UrologyPancreatic CancerGastrointestinal OncologyMedicineGastroenterology +7

High- versus low-dose levo-leucovorin as a modulator of 5-fluorouracil in advanced colorectal cancer: A ‘GISCAD’ phase III study

Roberto Labianca, Stefano Cascinu, L. Frontini, +15

Annals of Oncology

OncologyGastrointestinal OncologyMedicineColorectal CancerPharmacotherapy +4

Randomized Trial of Intraportal and/or Systemic Adjuvant Chemotherapy in Patients With Colon Carcinoma

Roberto Labianca, R. Fossati, Alberto Zaniboni, +10

JNCI Journal of the National Cancer Institute

Phase II trial of 5-fluorouracil and the natural l isomer of folinic acid in the treatment of advanced colorectal carcinoma

R. Rosso, Teresita Mazzei, Alberto Sobrero, +15

European Journal of Cancer

Medicinal ChemistrySurgical OncologyOncologyPhase Ii TrialMedicine +7